Roche Holding Ltd ADR (RHHBY OTCQX) stock market data APIs
$57.3534
-0.45(-0.8%)
as of February 11, 2026
Try our APIs with
free plan!
Roche Holding Ltd ADR Financial Data Overview
Price chart is built with
Anychart
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Prev. Close
57.3534
Open
56.9035
High
57.5883
Low
56.6498
52 wk Range
34.75-58.4
Market Cap
366 036 M
P/E Ratio
21.9421
Shares Outstanding
5 511 M
Revenue
63 356 M
Dividends (Yield)
0.0244
Beta
0.201
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Roche Holding Ltd ADR (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roche Holding Ltd ADR data using free add-ons & libraries
Get Roche Holding Ltd ADR Fundamental Data
Roche Holding Ltd ADR Fundamental data includes:
- Net Revenue: 63 356 M
- EBITDA: 24 044 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-01-29
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roche Holding Ltd ADR News
New
EXEL Q4 Earnings and Revenues Beat, Colorectal Cancer Drug in Focus
Exelixis, Inc. EXEL reported better-than-expected results for the fourth quarter of 2025. Adjusted earnings per share (EPS) of 94 cents comfortably beat the Zacks Consensus Estimate of 77 cents. The ...
International ETFs to Watch as Foreign Stock Markets Beat the US
In a dramatic shift in market leadership, 2025 marks the year international stock markets finally break the decade-long ‘U.S. exceptionalism’ trend. According to data from Morningstar, the Morning...
Here's What Will Drive AbbVie's Top-line Growth in 2026
AbbVie ABBV had an encouraging year in 2025, registering a sales growth of about 8.5% year over year at constant exchange rates. This number is impressive for a company that has been facing biosimilar...
Roche Holding (SWX:ROG) Valuation Check After Recent Share Price Momentum And Conflicting Fair Value Views
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. What recent performance says about Roche Holding shares Roche Holding (SWX:ROG...
Get Roche Holding Ltd ADR fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
